JPMorgan prefers these European chemicals stocks as China pressure grows
JPMorgan remains cautious on European chemicals, citing overcapacity and China competition. They note margin squeezes in Europe and downgrade 2027 earnings estimates. The bank favors Novonesis, Umicore, and Syensqo, while underweighting BASF, Wacker, and others. Industry consolidation is seen as a key path to improvement.
How this was made
The 30-second read
Why it matters
Analyst ratings and merger commentary provide fresh qualitative signals that may influence stock positioning.
Market read
The report offers new analyst perspectives that could affect pricing of several European chemical stocks.
What to watch
Potential policy support for green chemicals and supply‑chain resilience could benefit the sector.
Background
JPMorgan released an updated sector outlook for European chemicals, highlighting overcapacity, China competition, and merger opportunities.
Ticker impact
The Axalta merger with Akzo Nobel is cited as a sensible consolidation by JPMorgan.
potential 2‑4% increase pending deal closure
Merger perceived positively but impact limited until completion.
Market effects
JPMorgan's sector view may shift allocations across European chemicals stocks.
European chemical equities could see broader re‑rating pressure.
Limited to investors with exposure to European chemicals.
Counterpoint
Some investors may view the Underweight ratings as over‑pessimistic given recent cost‑pass‑throughs.
Key entities
- Research FirmJPMorgan
Provider of the sector outlook and ratings.
- CompanyNovonesis
Top long pick in the chemicals sector.
